Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
Plos One|July 30, 2010
Genetically dependent ERBB3 expression modulates antigen presenting cell function and type 1 diabetes riskHongjie Wang, Yulan Jin, M V Prasad Linga Reddy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2024
Co-occurring EGFR p.E709X Mutation Mediates Primary Resistance to the Third-Generation EGFR-TKIs in EGFR p.G719X-Mutant Patients with Advanced NSCLCLanlan Pang, Yihua Huang, Weitao Zhuang, et al.
Nature Communications|May 10, 2025
Surface lipoprotein sorting by crosstalk between Lpt and Lol pathways in gram-negative bacteriaQingshan Luo, Chengai Wang, Shuai Qiao, et al.
Lung Cancer (Amsterdam, Netherlands)|May 19, 2024
Rare SMARCA4-deficient thoracic tumor: Insights into molecular characterization and optimal therapeutics methodsMengting Shi, Lanlan Pang, Huaqiang Zhou, et al.
Human Vaccines & Immunotherapeutics|December 3, 2025
Immunogenicity of a recombinant subunit COVID-19 vaccine: A prospective, multi-centre, longitudinal study in Chinese Alzheimer's disease patientsYouhong Weng, Yihua Huang, Jiangtao Zhang, et al.
Neoplasia (New York, N.Y.)|October 4, 2024
Prenatal p25-activated Cdk5 induces pituitary tumorigenesis through MCM2 phosphorylation-mediated cell proliferationYingwei Huang, Qiqi Wang, Weiwei Zhou, et al.
ACS Omega|September 7, 2022
Molecular Dynamics Analysis of Fast-Spreading Severe Acute Respiratory Syndrome Coronavirus 2 Variants and Their Effects on the Interaction with Human Angiotensin-Converting Enzyme 2Anacleto Silva de Souza, Vitor Martins de Freitas Amorim, Gabriela D A Guardia, et al.
Cancer Discovery|March 24, 2026
The oncogenic EGFR-SHC1 fusion confers insensitivity to EGFR-TKI via dual activation of N-EGFR kinase domain and C-SHC1 phosphorylation sites in lung cancerJiani Zheng, Shen Zhao, Jianhua Zhan, et al.
Human Molecular Genetics|October 18, 2008
IFIH1 polymorphisms are significantly associated with type 1 diabetes and IFIH1 gene expression in peripheral blood mononuclear cellsSiyang Liu, Hongjie Wang, Yulan Jin, et al.
Nature Communications|June 12, 2023
Phase 1b trial of anti-EGFR antibody JMT101 and Osimertinib in EGFR exon 20 insertion-positive non-small-cell lung cancerShen Zhao, Wu Zhuang, Baohui Han, et al.
Pageof 13